Chilton Capital Management LLC Boosts Holdings in Corteva, Inc. $CTVA

Chilton Capital Management LLC increased its stake in shares of Corteva, Inc. (NYSE:CTVA) by 18.1% during the 3rd quarter, Holdings Channel.com reports. The fund owned 445,350 shares of the company’s stock after purchasing an additional 68,380 shares during the quarter. Chilton Capital Management LLC’s holdings in Corteva were worth $30,119,000 as of its most recent SEC filing.

Several other large investors also recently bought and sold shares of the stock. Gladwyn Financial Advisors Inc. acquired a new stake in shares of Corteva during the second quarter worth about $25,000. True Wealth Design LLC grew its stake in Corteva by 209.5% during the 3rd quarter. True Wealth Design LLC now owns 390 shares of the company’s stock worth $26,000 after buying an additional 264 shares during the last quarter. Total Investment Management Inc. acquired a new position in Corteva during the second quarter worth approximately $27,000. Curat Global LLC lifted its stake in Corteva by 93.7% in the second quarter. Curat Global LLC now owns 370 shares of the company’s stock valued at $28,000 after buying an additional 179 shares during the last quarter. Finally, Twin Peaks Wealth Advisors LLC purchased a new stake in Corteva in the second quarter valued at approximately $29,000. Institutional investors and hedge funds own 81.54% of the company’s stock.

Analysts Set New Price Targets

A number of equities analysts have recently commented on CTVA shares. UBS Group cut their target price on shares of Corteva from $85.00 to $81.00 and set a “buy” rating on the stock in a report on Thursday, October 30th. Argus raised shares of Corteva to a “strong-buy” rating in a report on Friday, January 16th. BNP Paribas Exane raised their price target on Corteva from $70.00 to $72.00 and gave the stock a “neutral” rating in a report on Monday, November 17th. Wells Fargo & Company dropped their price target on Corteva from $80.00 to $77.00 and set an “overweight” rating on the stock in a research report on Tuesday, November 11th. Finally, Oppenheimer reaffirmed an “outperform” rating and set a $76.00 price objective on shares of Corteva in a research report on Friday, November 7th. Two research analysts have rated the stock with a Strong Buy rating, fourteen have given a Buy rating and five have given a Hold rating to the company’s stock. According to MarketBeat.com, Corteva presently has an average rating of “Moderate Buy” and an average price target of $79.47.

Corteva Trading Up 1.3%

NYSE CTVA opened at $72.60 on Tuesday. The company has a quick ratio of 1.07, a current ratio of 1.58 and a debt-to-equity ratio of 0.07. The stock has a market capitalization of $49.06 billion, a P/E ratio of 31.03, a P/E/G ratio of 1.82 and a beta of 0.74. Corteva, Inc. has a 52-week low of $53.40 and a 52-week high of $77.41. The firm has a 50-day moving average price of $67.43 and a 200 day moving average price of $68.33.

Corteva (NYSE:CTVA) last issued its earnings results on Tuesday, November 4th. The company reported ($0.23) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.49) by $0.26. The business had revenue of $2.62 billion during the quarter, compared to the consensus estimate of $2.47 billion. Corteva had a return on equity of 9.37% and a net margin of 9.19%.The company’s revenue for the quarter was up 6.5% on a year-over-year basis. During the same period in the prior year, the business posted ($0.49) EPS. Equities research analysts expect that Corteva, Inc. will post 2.96 EPS for the current year.

Corteva Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Monday, December 15th. Stockholders of record on Monday, December 1st were issued a $0.18 dividend. This represents a $0.72 dividend on an annualized basis and a dividend yield of 1.0%. The ex-dividend date was Monday, December 1st. Corteva’s dividend payout ratio (DPR) is currently 30.77%.

Corteva Company Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.